HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK Probiotics Distribution Deal Latest Milestone In OptiBiotix Growth Journey

Executive Summary

UK probiotics specialist Optibiotix' CEO Stephen O'Hara speaks exclusively to HBW Insight about the firm's growth ambitions, which have not been held back by the coronavirus pandemic. 

You may also be interested in...



Novel Lactiplantibacillus Plantarum Probiotic Strain Shows Weight Management Potential – Study

A novel strain of the popular lactiplantibacillus plantarum probiotic species has delivered promising results in in a recent clinical trial exploring its use in weight management.

Activia Going With Its Gut: Targeting Young Consumers In Advertising Probiotics As 'Cool'

Danone North America’s Activia video campaign “A-to-Z” targets young women to make a connection between emotions and the complexity of the gut microbiome. The campaign will include four videos, with the first promoting a “bright, fun and musical” feel on the branded site and on YouTube.

Probiotics’ Efficacy Too Specific For General Look In ’60 Minutes’ Segment Critical Of Category

A recent segment of CBS News “60 Minutes” discussing potential health benefits from probiotics was highly criticized by groups including the Consumer Healthcare Products Association, the Council for Responsible Nutrition, the Natural Products Association and the International Probiotics Association.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS150223

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel